Notes of a Meeting for the Forward Planning & Monitoring Group Roll-Out of Recombinant Treatment for Adult Haemophilia Patients, on 6th September 2004 at Skipton House, Elephant & Castle. Refers to the following; Report of the first year of the roll-out, and this report should be published on the DH Website; Risk Analysis looked at Price/Volume of recombinant Products, Impact of new product development, Impact of the international market,Increased costs, and Risks arising from National / local contracts; Definition of eligibility of guidance notes; Allocations to PCTs for 2004/05; Allocations to PCTs for 20025/06m, and Final Report on the Audit 2003/04. Attendees Richard Gutowski; Julia Stallibrass; Stephen Dobra; Zubeda Seedat; Frank Hill; Charles Hay; Sybil Hirsch; Chris Theaker; Kendal Bird; Lucie Waters; Bridget Emanuel; Wendy ONeill; Ruth Taylor; Chris Hodgson.